The UK stock market has recently faced challenges, with the FTSE 100 index experiencing declines due to weak trade data from China and broader global economic concerns. As investors navigate these uncertain conditions, identifying stocks that are trading below their intrinsic value can present potential opportunities for those seeking to capitalize on mispriced assets. Top 10 Undervalued Stocks Based On Cash Flows In The United Kingdom Name Current Price Fair Value (Est) Discount (Est) Gaming Realms (AIM:GMR) £0.382 £0.76 49.8% GlobalData (AIM:DATA) £2.02 £3.71 45.6% AstraZeneca (LSE:AZN) £119.46 £237.15 49.6% Tracsis (AIM:TRCS) £5.42 £10.01 45.9% Franchise Brands (AIM:FRAN) £1.46 £2.63 44.5% Redcentric (AIM:RCN) £1.325 £2.44 45.8% Videndum (LSE:VID) £2.525 £4.99 49.4% Foxtons Group (LSE:FOXT) £0.62 £1.19 47.9% SysGroup (AIM:SYS) £0.335 £0.65 48.7% Hochschild Mining (LSE:HOC) £1.908 £3.53 46% Click here to see the full list of 60 stocks from our Undervalued UK Stocks Based On Cash Flows screener. Let's take a closer look at a couple of our picks from the screened companies. AstraZeneca Overview: AstraZeneca PLC is a biopharmaceutical company engaged in the discovery, development, manufacture, and commercialization of prescription medicines, with a market cap of approximately £185.20 billion. Operations: AstraZeneca's revenue segment is primarily derived from its biopharmaceuticals division, which generated $49.13 billion. Estimated Discount To Fair Value: 49.6% AstraZeneca is trading at £119.46, significantly below its estimated fair value of £237.15, suggesting potential undervaluation based on discounted cash flow analysis. Despite high debt levels and moderate earnings growth forecasts of 16.5% annually, the stock's price reflects a substantial discount to intrinsic value. Recent strategic alliances and clinical advancements in oncology indicate robust operational momentum, potentially enhancing future cash flows despite current financial constraints. Insights from our recent growth report point to a promising forecast for AstraZeneca's business outlook. Get an in-depth perspective on AstraZeneca's balance sheet by reading our health report here. LSE:AZN Discounted Cash Flow as at Oct 2024 Gulf Keystone Petroleum Overview: Gulf Keystone Petroleum Limited is involved in the exploration, development, and production of oil and gas in the Kurdistan Region of Iraq with a market cap of £256.79 million. Operations: The company's revenue is primarily derived from its exploration and production activities in oil and gas, amounting to $115.15 million. Estimated Discount To Fair Value: 42.5% Gulf Keystone Petroleum is trading at £1.18, well below its estimated fair value of £2.06, indicating significant undervaluation based on discounted cash flow analysis. The company is forecast to become profitable within three years, with revenue growth expected to outpace the UK market substantially at 42.8% per year. Recent board changes include appointing two experienced Non-Executive Directors, potentially strengthening governance and strategic oversight amid ongoing share buybacks and improving earnings performance. According our earnings growth report, there's an indication that Gulf Keystone Petroleum might be ready to expand. Dive into the specifics of Gulf Keystone Petroleum here with our thorough financial health report. LSE:GKP Discounted Cash Flow as at Oct 2024 W.A.G payment solutions Overview: W.A.G payment solutions plc operates an integrated payments and mobility platform targeting the commercial road transportation industry primarily in Europe, with a market cap of £565.37 million. Operations: The company's revenue is derived from its Payment Solutions segment, which generated €2.10 billion, and its Mobility Solutions segment, which contributed €124.13 million. Estimated Discount To Fair Value: 12.5% W.A.G payment solutions is trading at £0.82, slightly below its estimated fair value of £0.94, suggesting some undervaluation based on cash flow analysis. The company reported H1 2024 sales of €1.15 billion but saw a decline in net income to €2.43 million from the previous year, indicating challenges in profitability despite revenue growth forecasts exceeding the UK market rate at 8.9% annually. Analysts anticipate a stock price increase by 44.3%. Our expertly prepared growth report on W.A.G payment solutions implies its future financial outlook may be stronger than recent results. Take a closer look at W.A.G payment solutions' balance sheet health here in our report. LSE:WPS Discounted Cash Flow as at Oct 2024 Where To Now? Unlock our comprehensive list of 60 Undervalued UK Stocks Based On Cash Flows by clicking here. Got skin in the game with these stocks? Elevate how you manage them by using Simply Wall St's portfolio, where intuitive tools await to help optimize your investment outcomes. Maximize your investment potential with Simply Wall St, the comprehensive app that offers global market insights for free. Searching for a Fresh Perspective? Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include LSE:AZN LSE:GKP and LSE:WPS. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected]
3 UK Stocks Estimated To Be Trading Below Their Intrinsic Value
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...